Doyle Thomas James (CIK 0001910331)

Latest company ownership

KURA - Kura Oncology, Inc.

Role: SVP, Finance & Accounting

Shares held

500

Last filed at

Nov 14, 2025

Confidence Score

91.2

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 13, 2025	Nov 14, 2025	Kura Oncology, Inc.	SVP, Finance & Accounting	Sell	95.0	+20,428	18.52%	✗	$50.7K
Sep 27, 2025	Sep 29, 2025	Kura Oncology, Inc.	SVP, Finance & Accounting	Sell	91.3	+20,425	22.72%	✗	$40.6K
Jan 28, 2025	Jan 28, 2025	Kura Oncology, Inc.	SVP, Finance & Accounting	Sell	26.3	-4,949	-5.29%	✗	$39K
Jan 29, 2024	Jan 31, 2024	Kura Oncology, Inc.	SVP, Finance & Accounting	Sell	26.3	-2,318	-4.55%	✗	$41.3K
Jan 27, 2023	Jan 31, 2023	Kura Oncology, Inc.	SVP, Finance & Accounting	Sell	26.3	-1,548	-8.20%	✗	$21.5K